Citation Impact
Citing Papers
Programmed cell death 1 ligand 1 and tumor-infiltrating CD8 + T lymphocytes are prognostic factors of human ovarian cancer
2007 StandoutNobel
Dendritic Cell Targeting of Survivin Protein in a Xenogeneic Form Elicits Strong CD4+ T Cell Immunity to Mouse Survivin
2006 StandoutNobel
Myeloid-Derived Suppressor Cells: Linking Inflammation and Cancer
2009 Standout
A Combination of Chemoimmunotherapies Can Efficiently Break Self-Tolerance and Induce Antitumor Immunity in a Tolerogenic Murine Tumor Model
2007 StandoutNobel
Normal Tissue Complication Probability (NTCP) Modelling of Severe Acute Mucositis using a Novel Oral Mucosal Surface Organ at Risk
2017
Head and neck squamous cell carcinoma
2020 Standout
Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2024 Standout
Prevention of cervical cancer through papillomavirus vaccination
2004
Specific Antibody Levels at the Cervix During the Menstrual Cycle of Women Vaccinated With Human Papillomavirus 16 Virus-Like Particles
2003
Human Leukocyte Antigen (HLA) Class I Defects in Head and Neck Cancer: Molecular Mechanisms and Clinical Significance
2005
Interaction of human papillomaviruses with the host immune system: A well evolved relationship
2008
Immune evasion in human papillomavirus-associated cervical cancer
2002
Effector and memory T-cell differentiation: implications for vaccine development
2002 Standout
Head and neck cancer
2008 Standout
Immunosuppressive Tumor Microenvironment in Cervical Cancer Patients
2011
Mucosal immunity and vaccines
2005 Standout
The emerging role of trans-oral robotic surgery for the detection of the primary tumour site in patients with head-neck unknown primary cancers: A meta-analysis
2019
Myeloid-derived suppressor cells as regulators of the immune system
2009 Standout
Enhancement of antitumour immunity by a novel chemotactic antigen DNA vaccine encoding chemokines and multiepitopes of prostate‐tumour‐associated antigens
2006
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
The Invisible Enemy – How Human Papillomaviruses Avoid Recognition and Clearance by the Host Immune System
2012
Human papillomavirus and cervical cancer
2007 Standout
Strategies for designing and optimizing new generation vaccines
2001
Impact of the first wave of the COVID-19 pandemic on cancer registration and cancer care: a European survey
2021
Development of therapeutic HPV vaccines
2009
Paradoxical roles of the immune system during cancer development
2006 Standout
Protective Efficacy of Multiepitope Human Leukocyte Antigen???A*0201 Restricted Cytotoxic T-Lymphocyte Peptide Construct Against Challenge With Human T-Cell Lymphotropic Virus Type 1 Tax Recombinant Vaccinia Virus
2004
A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models
2019 Standout
Therapeutic Vaccination for HPV Induced Cervical Cancers
2007
The efficacy of DNA vaccination is enhanced in mice by targeting the encoded protein to dendritic cells
2008 StandoutNobel
Disruption of c-mos causes parthenogenetic development of unfertilized mouse eggs
1994 StandoutNatureNobel
Microenvironmental regulation of tumor progression and metastasis
2013 Standout
REVIEW ARTICLE: Cytokine Gene Polymorphisms in Recurrent Spontaneous Abortions: A Comprehensive Review
2008
Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures
2013 Standout
ESHRE guideline: recurrent pregnancy loss
2018 Standout
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Exploiting dendritic cells to improve vaccine efficacy
2002 StandoutNobel
Complementary Role of CD4+ T Cells and Secondary Lymphoid Tissues for Cross-presentation of Tumor Antigen to CD8+ T Cells
2003
Intensified and protective CD4+ T cell immunity in mice with anti–dendritic cell HIV gag fusion antibody vaccine
2006 StandoutNobel
The Three Es of Cancer Immunoediting
2004 Standout
Immunization of woodchucks with adjuvanted sHDAg (p24): immune response and outcome following challenge
2003 StandoutNobel
The role of transoral robotic surgery, transoral laser microsurgery, and lingual tonsillectomy in the identification of head and neck squamous cell carcinoma of unknown primary origin: A systematic review
2016
Rising prevalence of human papillomavirus–related oropharyngeal cancer in Australia over the last 2 decades
2014
Human Papillomavirus and Cervical Cancer
2003 Standout
Association of cervical cancer with the presence of CD4+regulatory T cells specific for human papillomavirus antigens
2007
Unique potential of 4-1BB agonist antibody to promote durable regression of HPV + tumors when combined with an E6/E7 peptide vaccine
2015 StandoutNobel
Epidemiology of Human Papillomavirus–Positive Head and Neck Squamous Cell Carcinoma
2015 Standout
Mechanism of Immune Dysfunction in Cancer Mediated by Immature Gr-1+ Myeloid Cells
2001
Low-Dose Adenovirus Vaccine Encoding Chimeric Hepatitis B Virus Surface Antigen-Human Papillomavirus Type 16 E7 Proteins Induces Enhanced E7-Specific Antibody and Cytotoxic T-Cell Responses
2005 StandoutNobel
Germ Cell Tumors
1992
Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells
2005 StandoutNobel
Correlates of Protection Induced by Vaccination
2010 Standout
Works of Mererid Evans being referenced
PATHOS: a phase II/III trial of risk-stratified, reduced intensity adjuvant treatment in patients undergoing transoral surgery for Human papillomavirus (HPV) positive oropharyngeal cancer
2015
Human Papillomavirus-associated oropharyngeal cancer: an observational study of diagnosis, prevalence and prognosis in a UK population
2013
Expression and Regulation of Vascular Endothelial Growth Factor in a First Trimester Trophoblast Cell Line
2000
The impact of the COVID-19 pandemic on radiotherapy services in England, UK: a population-based study
2021
Antigen Processing Defects in Cervical Carcinomas Limit the Presentation of a CTL Epitope from Human Papillomavirus 16 E6
2001
Defined Flanking Spacers and Enhanced Proteolysis Is Essential for Eradication of Established Tumors by an Epitope String DNA Vaccine
2001
Multicentric human papillomavirus–associated head and neck squamous cell carcinoma
2013
Primary trabecular carcinoid tumor of the ovary
1982
First results of COSTAR: A randomised trial of 3-dimensional conformal radiotherapy (3DCRT) vs cochlea-sparing intensity modulated radiotherapy (CS-IMRT) in patients with parotid cancer.
2016